HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Volume 20, No. 8, August 2016 – Novel Technologies for Antibody Drug Discovery in Japan       » Global Experts Convene to Discuss China's Plan for Diabetes Prevention and Rehabilitation in 2016       » Butterflies Offer Climate Scientists Ecological Insights       » Thermal Stability of Camelid Single Domain VHH Antibody       » That Gut Feeling: How A Healthy Digestive System Has Everything To Do With It       » World Heart Day - At the Heart of Health      
BIOBOARD - INSIDE INDUSTRY
Danziger Innovations and Precision BioSciences collaborate on genome modification in ornamental plants
Danziger Innovations and Precision BioSciences have successfully generated site-specific genome modifications in petunia and jasmine tobacco by combining Precision's Directed Nuclease Editor (DNE) gene editing technolgy with Danziger's MemoGene gene delivery system. This successful research effort was aimed at genetic control of flower color but researchers at Precision and Danziger believe that the approach can be used more broadly to address genome engineering challenges in plants that are recalcitrant to existing transformation methods without requiring the insertion of foreign DNA into the plant genome.

Danziger Innovations is an Israeli biotechnology company engaged in the discovery and manufacture of new advanced breeding solutions to improve traits in crops for the world agricultural community's needs. Precision BioSciences is a biotechnology company focused on developing and commercializing therapeutics and services based on its ability to enable site-specific genome modifications within a living organism.

"While DNE has a long and successful history in major row crops, we see a significant commercial opportunity in ornamentals and other high-value plants"

Precision's DNE technology is a proprietary method for making site-specific modifications to complex genomes. The current version of the technology can create virtually any desired genetic change without the high-levels of off-target modification that are often seen with alternative genome engineering methods.

Danziger's MemoGene technology is a proprietary, viral-based technology for precise gene modifications, using highly innovative tools to deliver endonucleases to specific compartments in the plant cell by uniquely designed viral vectors. The MemoGene solution bypasses current biotechnological barriers and offers two main consumer applications: Deletion and Insertion/Substitution of DNA sequences to create new, commercially desirable "tailor-made" varieties of field, vegetable, woody and ornamental crops.

"While DNE has a long and successful history in major row crops, we see a significant commercial opportunity in ornamentals and other high-value plants," said Derek Jantz, Precision's VP of Scientific Development. "MemoGene will allow us to work in numerous such species that do not have established transformation protocols and potentially reduce regulatory burdens."

"We are very pleased with this cooperation. Using the MemoGene and DNE technologies together creates a synergy that shall lead to the creation of new and improved varieties, with novel traits," said Micha Danziger, CEO of Danziger Innovations. "Using our MemoGene Deletion technology allows us to create a mutated plant, without leaving any trace of foreign DNA in plant genome. We may achieve the predictable results at reduced time and cost."

Source: Business Wire

Click here for the complete issue.

NEWS CRUNCH  
news CPhI's Pre-Connect Congress outlines current trends in pharma
news World Population Day 2016
news NUS Student Clinches Top Prize at National Smart Mapping Competition with Cutting-Edge Food Security Solution
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2016
January:
Guest Editorial - Biotechnology In Korea
February:
Guest Editorial - Biomedical Research Governance
March:
Guest Editorial - Life-Saving Opportunities: A Guide to Regenerative Medicine
April:
Leading-Edge ONCOLOGY
May:
Healthcare Systems & Policies in Asia
June:
Medical Devices & Healthcare Technology
July:
Water Technology and Management
August:
Novel Technologies for Antibody Drug Discovery in Japan
September:
Infectious Diseases
October:
Medical Tourism
November:
Big Data in Healthcare
December:
Evidence-based TCM
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com or Mr Edward
Copyright© 2016 World Scientific Publishing Co Pte Ltd  •  Privacy Policy